Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Diabetes & Metabolic Disorders
Erschienen in: Journal of Diabetes & Metabolic Disorders 1/2020

05.03.2020 | Review article

Chromium Supplementation; Negotiation with Diabetes Mellitus, Hyperlipidemia and Depression

verfasst von: Amir Khodavirdipour, Fatemeh Haddadi, Shiva Keshavarzi

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Chromium (Cr) is an essential trace element which found naturally in a daily diet and available in the form of supplementary tablets to boost disorders like diabetes mellitus (DM) and functions like lipid metabolism and beneficial on depression too. Diabetes is one of the most prevalent endocrine diseases or in other words, the most severe metabolic syndrome (MS), which associated with high production of free-radicals which is out of bodies detoxifying machine capacity or high oxidative stress (HOS), vasculitis and elevated lipid profile. many research papers and clinical trials published about the significance of chromium on biological activities, pre and post clinical. For this review research articles, clinical trials, from 1st Jan’10 to 31st Dec’18 and refer literature for the biochemical, pharmacological and biological activity of Chromium. Primarily articles gathered from the above search engines. Then precisely according to our aim and goal and regarding designed objectives dismisses similar articles and finally came to 84 articles for the above said period. This review trying to cover the entire picture from what chromium is to the recent updates on their greater role in increasing insulin sensitivity of cells and enhancing lipid metabolism and even recent findings suggest its positive effects including prevention and ameliorating properties on depression. The biological activities, pharmacological features, clinical implications including efficacy and role of chromium compounds on the glycaemic index will be discussed. The outcome of this review is to bring the pros and cons of chromium supplementation along with is safety and toxicity concern beside molecular pathways, biochemistry and clinical trials, all in one comprehensive review.
Literatur
1.
Wilbur S, Abadin H, Fay M, Yu D, and Tencza B, Ingerman L, Klotzbach J, and James S. Textbook: toxicological profile for chromium. Division of Toxicology, Agency for Toxic Substances and Disease Registry, 1600 Clifton Road, Mailstop E-29, Atlanta, Georgia 30333; 2000.
2.
3.
Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr. 1998;17(6):548–55.PubMedCrossRef
4.
Anderson RA. Chromium in the prevention and control of diabetes. Diabetes Metab. 2000;26(1):22–8.PubMed
5.
Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care. 2004;27(11):2741–51.PubMedCrossRef
6.
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States. JAMA. 2006;295(13):1549–55.PubMedCrossRef
7.
8.
Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–32.PubMedCrossRef
9.
Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9.PubMedCrossRef
10.
Popkin BM. Recent dynamics suggest selected countries catching up to US obesity. Am J Clin Nutr. 2010;91:284–8.CrossRef
11.
Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235–41.PubMedCrossRef
12.
Koh-Banerjee P, Wang Y, Hu FB, Spiegelman D, Willett WC, Rimm EB. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol. 2004;159:1150–9.PubMedCrossRef
13.
Yeghiazaryan K, Schild H, Golubnitschaja O. Chromium-picolinate therapy in diabetes care: individual outcomes require new guidelines and navigation by predictive diagnostics. Infect Disord Drug Targets. 2012;12(5):332–9.PubMedPubMedCentralCrossRef
14.
Glaser E, Halpern G. Uber Die Aktivierung des Insulins Durch Hefeprebasft. Biochem Z. 1929;207:377–83 (Article in German).
15.
Schwarz K, Mertz W. A glucose tolerance factor and its differentiation from factor 3. Arch Biochem Biophys. 1957;72(2):515–8.PubMedCrossRef
16.
Colapinto ND, Bedard P, Goldman BS. Bloodstream infection associated with prolonged intravenous therapy. Canadian journal of surgery. Journal canadien de chirurgie. 1972;15(1):27–9.PubMed
17.
Chen YL, Lin JD, Hsia TL, Mao FC, Hsu CH, Pei D. The effect of chromium on inflammatory markers, 1st and 2nd phase insulin secretionin type 2 diabetes. Eur J Nutr. 2014;53(1):127–33.PubMedCrossRef
18.
Wilson BE, Gondy A. Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. Diabetes Res Clin Pract. 1995;28(3):179–84.PubMedCrossRef
19.
San Mauro Martín I, Ruiz León AM, Garicano Vilar E, Camina Martín MA, de Mateo-Silleras B, de Paz Redondo del Río M and et al. Chromium supplementation in patients with type 2 diabetes and high risk of type 2 diabetes: a meta-analysis of randomized controlled trials. Nutr Hosp. 2016; 33(1).
20.
Aziza AK and El Mugdad AA Preparation, characterization and biological activity Chromium Phthalocyanine chloride complex. 2012 Dept. of chem. Sudan university of science and technology (SUST).
21.
22.
23.
Bury TF, van Vroonhoven TJ, Stuifbergen WN. The role of surgical intervention in the treatment of patients with Crohn's disease. Ned Tijdschr Geneeskd. 1988;132(53):2414.PubMed
24.
Rains JL, Jain SK. Oxidative stress, insulin signalling and diabetes. Free Radic Biol Med. 2011;50:567–75.CrossRefPubMed
25.
Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 2003;546:113–20.PubMedCrossRef
26.
Kemp BE, Stapleton D, Campbell DJ, Chen ZP, Murthy S, Walter M, et al. AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans. 2003;31:162–8.PubMedCrossRef
27.
Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem. 1995;270:17513–20.PubMedCrossRef
28.
Winder WW, Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Phys. 1996;270:E299–304.
29.
Rutter GA, Da Silva XG, Leclerc I. Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J. 2003;375:1–16.PubMedPubMedCentralCrossRef
30.
Balk EM, Tatsioni A, Lichtenstein AH, Lau J, Pittas AG. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care. 2007;30(8):2154–63.PubMedCrossRef
31.
Yechoor VK, Patti M-E, Ueki K, Laustden PG, Saccone R, Rauniyar R, et al. Distinct pathways of insulin-regulated vs diabetes-regulated gene expression: an in vivo analysis in MIRKO mice. Proc Natl Acad Sci U S A. 2004;101(47):16525–30.PubMedPubMedCentralCrossRef
32.
Sun Y, Ramirez J, Woski SA, Vincent JB. The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferrin and chromium picolinate to LMWCr. JBIC J Biol Inorg Chem. 2000;5(1):129–36.PubMedCrossRef
33.
Hepburn DD, Vincent JB. Tissue and subcellular distribution of chromium picolinate with time after entering the bloodstream. J Inorg Biochem. 2003;94:86–93.PubMedCrossRef
34.
Wasser WG, Feldman NS, D’Agati VD. Chronic renal failure after ingestion of over-the-counter chromium picolinate (Letter). Ann Intern Med. 1997;126:410.PubMedCrossRef
35.
Institute of Medicine (IOM). Chromium picolinate: prototype monograph. In Dietary Supplements: A Framework for Evaluating Safety. Washington, DC, Institute of Medicine, 2004; p. B1-B80.
36.
Berner TO, Murphy MM, Slesinski R. Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement. Food Chem Toxicol. 2004;42:1029–42.PubMedCrossRef
37.
Jeejeebhoy KN. The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr Rev. 1999;57:329–35.PubMedCrossRef
38.
Brownley KA, Boettiger CA, Young L, Cefalu WT. Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating. Med Hypotheses. 2015;85(1):45–8.PubMedPubMedCentralCrossRef
39.
Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 1977;30(4):531–8.PubMedCrossRef
40.
Prasad A. Role of chromium compounds in diabetes. Indian J Pharm Pharmacol. 2016;3(1):17–23.CrossRef
41.
Gröber U, Kisters K, Schmidt J. Micronutrients in diabetology: complementary medicine update 2014. Med Monatsschr Pharm. 2014;37(8):284–92.PubMed
42.
Jacobs E, Hoyer A, Brinks R, Icks A, Kuß O, Rathmann W. Healthcare costs of Type 2 diabetes in Germany. Diabet Med. 2017;34(6):855–61.PubMedCrossRef
43.
Suksomboon N, Poolsup N, Yuwanakorn A. Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. J Clin Pharm Ther. 2014;39(3):292–306.PubMedCrossRef
44.
Rotter I, Kosik-Bogocka D, Dolegowska B, Safranow K, Lubkowska A, Laszczynska M. Relationship between the concentration of heavy metals and bio elements in aging men with metabolic syndrome. Int J Environ Res Public Health. 2015;12(4):3944–61.PubMedPubMedCentralCrossRef
45.
Sharma S, Agarwal RP, Choudhary M, Jain S, Goyal S, Agarwal V. Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes. J Trace Elem Med Biol. 2011;25(3):149–53.PubMedCrossRef
46.
Li Y, Li S, Meng X, Gan R-Y, Zhang J-J, Li H-B. Dietary Natural Products for Prevention and Treatment of Breast Cancer. Nutrients. 2017;9:728.PubMedCentralCrossRef
47.
Lang UE, Beglinger C, Schweinfurth N, Walter M, Borgwardt S. Nutritional aspects of depression. Cell Physiol Biochem. 2015;37(3):1029.PubMedCrossRef
48.
Anderson RA, Polansky MM, Bryden NA, Bhathena SJ, Canary JJ. Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metab Clin Exp. 1987;36(4):351–5.PubMedCrossRef
49.
Sylvia LG, Peters AT, Deckersbach T, Nierenberg AA. Nutrient-based therapies for bipolar disorder: a systematic review. Psychother Psychosom. 2013;82(1):10–9.PubMedCrossRef
50.
Amann BL, Mergl R, Vieta E, Born C, Hermisson I, Seemueller F, et al. A 2-year, open-label pilot study of adjunctive chromium in patients with treatmentresistant rapid-cycling bipolar disorder. J Clin Psychopharmacol. 2007;2(7):104–6.CrossRef
51.
Attenburrow MJ, Williams C, Odonliatis J, Powell J, Van de Ouderaa F, Williams M, et al. The effect of a nutritional source of tryptophan on dieting-induced changes in brain 5HT function. Psychol Med. 2003;33(8):1381–6.PubMedCrossRef
52.
Młyniec K, Davies CL, de Agueero Sanchez IG, Pytka K, Budziszewska B, Nowak G. Essential elements in depression and anxiety. Part I. Pharmacol Rep. 2014;66(4):534–44.PubMedCrossRef
53.
Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem. 2013;31:761–77.PubMedCrossRef
54.
Whitfield P, Parry-Strong A, Walsh E, Weatherall M, Krebs JD. The effect of a cinnamon-, chromium-and magnesium-formulated honey on glycaemic control, weight loss and lipid parameters in type 2 diabetes: an open-label cross-over randomised controlled trial. Eur J Nutr. 2016;55(3):1123–31.PubMedCrossRef
55.
56.
Azimi P, Ghiasvand R, Feizi A, Hosseinzadeh J, Bahreynian M, Hariri M, et al. Effect of cinnamon, cardamom, saffron and ginger consumption on blood pressure and a marker of endothelial function in patients with type 2 diabetes mellitus: A randomized controlled clinical trial. Blood Press. 2016;25(3):133–40.PubMedCrossRef
57.
Mirfeizi M, Mehdizadeh Tourzani Z, Mirfeizi SZ, Asghari Jafarabadi M, Rezvani HR, Afzali M. Controlling type 2 diabetes mellitus with herbal medicines: A triple-blind randomized clinical trial of efficacy and safety. J Diabetes. 2016;8(5):647–56.PubMedCrossRef
58.
Liu Y, Cotillard A, Vatier C, Bastard JP, Fellahi S, Stévant M, et al. A dietary supplement containing cinnamon, chromium and carnosine decreases fasting plasma glucose and increases lean mass in overweight or obese pre-diabetic subjects: a randomized, placebo-controlled trial. PLoS One. 2015;10(9):e0138646.PubMedPubMedCentralCrossRef
59.
McIver DJ, Grizales AM, Brownstein JS, Goldfine AB. Risk of Type 2 Diabetes Is Lower in US Adults Taking Chromium-Containing Supplements. J Nutr. 2015;145(12):2675–82.PubMedPubMedCentralCrossRef
60.
Peruzzu A, Solinas G, Asara Y, Forte G, Bocca B, Tolu F, et al. Association of trace elements with lipid profile and glycaemic control in patients with type 1 diabetes mellitus in northern Sardinia, Italy: An observational study. Chemosphere. 2015;132:101–7.PubMedCrossRef
61.
Paiva AN, de Lima JG, de Medeiros AC, Figueiredo HA, de Andrade RL, Ururahy MA, et al. Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: a randomized clinical study. J Trace Elem Med Biol. 2015;32:66–72.PubMedCrossRef
62.
Hansen AF, Simić A, Åsvold BO, Romundstad PR, Midthjell K, Syversen T, et al. Trace elements in early phase type 2 diabetes mellitus-A population-based study. The HUNT study in Norway. J Trace Elem Med Biol. 2017;40:46–53.PubMedCrossRef
63.
Smic A, Hansen AF, Asvold BO, Romundstud PR, Midthjell K, Syversen T, et al. Trace elements status in patients with type 2 diabetes in Norway: the HUNT3 survey. J Trace Elem Med Biol. 2017;41:91–8.CrossRef
64.
Harani H, Otmane A, Makrelouf M, Ouadahi N, Abdi A, Berrah A, et al. Preliminary evaluation of the antioxidant trace elements in an Algerian patient with type 2 diabetes: special role of manganese and chromium. Ann Boil Clin (Paris). 2012;70(6):669–77.
65.
Basaki M, Saeb M, Nazifi S, Shamsaei HA. Zinc, copper, iron, and chromium concentrations in young patients with type 2 diabetes mellitus. Biol Trace Elem Res. 2012;148(2):161–4.PubMedCrossRef
66.
Adam AM, Sharshar T, Mohamed MA, Ibrahim OB, Refat MS. Study of chemical bonding, physical and biological effect of metformin drug as an organized medicine for diabetes patients with chromium (III) and vanadium (IV) ions. Spectrochim Acta A Mol Biomol Spectrosc. 2015;149:323–32.PubMedCrossRef
67.
Gröber U, Kister K, Schmidt J: Micronutrients in diabetology: complementary medicine. Med Monatsschr Pharm 2004 Aug. Lang: German.
68.
Vincent JB. Elucidating a biological role for chromium at a molecular level. Acc Chem Res. 2000;33(7):503–10.PubMedCrossRef
69.
Abraham AS, Brooks BA, Eylath U. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metab Clin Exp. 1992;41(7):768–71.PubMedCrossRef
70.
Bahijiri SM, Mira SA, Mufti AM, Ajabnoor MA. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Saudi Med J. 2000;21(9):831–7.PubMed
71.
Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care. 1994;17(12):1449–52.PubMedCrossRef
72.
Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46(11):1786–91.PubMedCrossRef
73.
Ghosh D, Bhattacharya B, Mukherjee B, Manna B, Sinha M, Chowdhury J, et al. Role of chromium supplementation in Indians with type 2 diabetes mellitus. J Nutr Biochem. 2002;13(11):690–7.PubMedCrossRef
74.
Chen SH, Sun YP, Chen XS. Effect of jiangtangkang on blood glucose, sensitivity of insulin and blood viscosity in non-insulin dependent diabetes mellitus. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997;17(11):666–8.PubMed
75.
Uusitupa MI, Kumpulainen JT, Voutilainen E, Hersio K, Sarlund H, Pyörälä KP, et al. Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr. 1983;38(3):404–10.PubMedCrossRef
76.
Rabinowitz MB, Gonick HC, Levin SR, Davidson MB. Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care. 1983;6(4):319–27.PubMedCrossRef
77.
Uusitupa MI, Mykkänen L, Siitonen O, Laakso M, Sarlund H, Kolehmainen P, et al. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Br J Nutr. 1992;68(1):209–16.PubMedCrossRef
78.
Offenbacher EG, Pi-Sunyer FX. Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes. 1980;29(11):919–25.PubMedCrossRef
79.
Evans GW. The effect of chromium picolinate on insulin controlled parameters in humans. Int J Biosoc Med Res. 1989;11(2):163–80.
80.
Roeback JR, Hla KM, Chambless LE, Fletcher RH. Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers: a randomized, controlled trial. Ann Intern Med. 1991;115(12):917–24.PubMedCrossRef
81.
Riales R, Albrink MJ. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr. 1981;34(12):2670–8.PubMedCrossRef
82.
Press RI, Geller J, Evans GW. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med. 1990;152(1):41.PubMedPubMedCentral
83.
Preuss HG, Wallerstedt D, Talpur N, Tutuncuoglu SO, Echard B, Myers A, et al. Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study. J Med. 2000;31(5-6):227–46.PubMed
84.
Volpe SL, Huang HW, Larpadisorn K, Lesser II. Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program. J Am Coll Nutr. 2001;20(4):293–306.PubMedCrossRef
85.
Amato P, Morales AJ, Yen SS. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women. J Gerontol Ser A Biol Med Sci. 2000;55(5):M260–3.CrossRef
86.
Cefalu WT, Bell-Farrow AD, Stegner J, Wang ZQ, King T, Morgan T, et al. Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exp Med. 1999;12(2):71–83.CrossRef
Metadaten
Titel
Chromium Supplementation; Negotiation with Diabetes Mellitus, Hyperlipidemia and Depression
verfasst von
Amir Khodavirdipour
Fatemeh Haddadi
Shiva Keshavarzi
Publikationsdatum
05.03.2020
Verlag
Springer International Publishing
Erschienen in
Journal of Diabetes & Metabolic Disorders / Ausgabe 1/2020
Elektronische ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00501-8

Weitere Artikel der Ausgabe 1/2020

Journal of Diabetes & Metabolic Disorders 1/2020 Zur Ausgabe

Research article

Excess serum uric acid is associated with metabolic syndrome in obese adolescent patients

Research article

High intensity interval training improves diabetic cardiomyopathy via miR-1 dependent suppression of cardiomyocyte apoptosis in diabetic rats

Research article

Safety and efficacy of Berberis integerrima root extract in patients with type 2 diabetes. A parallel intervention based triple blind clinical trial

Research article

The study of eye care behaviors in patients with type 2 diabetes

Research article

Main gut bacterial composition differs between patients with type 1 and type 2 diabetes and non-diabetic adults

Research article

Comparison between calcium channel blocker with angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker combination on the development of new-onset diabetes in hypertensive Korean patients

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 | Parkinson-Krankheit | Nachrichten

Viel Bewegung in der Parkinsonforschung

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise